Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

racavalli 51 posts  |  Last Activity: Jul 3, 2016 9:21 AM Member since: Jul 31, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Will be listening closely to the call on Tuesday to hear what management has to say.

    Personally, I believing it may a dosing issue of too little.

    Phase II successful trial used single 10 ml injection

    Safety Seven blowout results used TRIPLE INJECTIONS OF 4 ml

    The failed trial used SINGEL 4 ML INJECTION

    With no known adverse side effects, and disappointing efficacy in the recent trial, one possibility is that Ampion may have under dosed.

    The dosing trial to choose between 4 ml and 10 ml was very small and may have misled critical dosing decisions.

    Jury is out but I strongly believe the drug still works and will be a huge success when better designed trial happens.

    Price is all time low and an excellent opportunity to average down.

    Company should be able to raise adequate funds with their ATM without extreme dilution.

    Management can take huge pay cuts and stop spending across the board until they meet with success.

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 8 DAYS OR LESS to cover short positions.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    Ampion is a Mega Blockbuster drug easily capable of generating over $5 billion per year.

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares could easily be trading over $6 when news hits and will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

  • racavalli racavalli Jun 28, 2016 11:12 AM Flag

    the big 3 million plus share trade on the close was the Russell rebalancing.

    the obvious question is . . . who was the seller . . . and the obvious answer is the sell side was most likely another short sale.

    the stage is set for a pretty painful short squeeze if results are positive because they already have fda approval if they just meet the endpoint in this trial

    results are likely to be positive because

    1. safety is the primary goal and out of over 1000 patients receiving campion in previous trials, there has never been even on adverse side effect from the drug

    2. efficacy has ALWAYS been proven and the only failures were the results of a shipment of frozen drug and then the erratic placebo. never the drug

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 8 DAYS OR LESS to cover short positions.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    Ampion is a Mega Blockbuster drug easily capable of generating over $5 billion per year.

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares could easily be trading over $6 when news hits and will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon.

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 9 DAYS OR LESS to cover short positions.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    Ampion is a Mega Blockbuster drug easily capable of generating over $5 billion per year.

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares could easily be trading over $6 when news hits and will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon.

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 10 DAYS OR LESS to cover short positions.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    Ampion is a Mega Blockbuster drug easily capable of generating over $5 billion per year.

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 11 DAYS OR LESS to cover

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • racavalli racavalli Jun 24, 2016 8:55 AM Flag

    will it happen today or????

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 12 DAYS OR LESS to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 13 DAYS OR LESS to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • racavalli racavalli Jun 22, 2016 9:38 AM Flag

    Strange how you sound EXACTLY like Billwilliams386

    Are you another alias of BW?

    Sentiment: Strong Buy

  • What could Billwilliams 836 motive be for posting so many negative comments just before the BIG NEWS IS ABOUT TO HIT? How only motive could be to discredit ampio to try to drive prices lower so he and his short partners can cover before the price explodes upward.

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 14 DAYS OR LESS to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • Plus final trial results (MOST LIKEY TO ACHIEVE FDA TARGET) within 15 days or less of being announced.

    Holders of 7.5 million shares short have nowhere to go!

    It's SQEEZE TIME!!!!!

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 15 DAYS OR LESS to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 16 DAYS OR LESS to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 18 DAYS OR LESS to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 19 days or less to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • Short interest is increasing in the face of inevitable news that will cause major short squeeze.

    Only 20 days or less to cover or to buy call options to hedge.

    After two disappointing trials that caused management major pain, THIS TRIAL WON'T MISS!

    EFFICACY AND SAFETY HAVE NEVER BEEN AN ISSUE WITH THE FAILED TRIALS!

    FIRST FAILED TRIAL WAS DUE TO FROZEN AMPION

    SECOND FAILED TRIAL WAS DUE TO ERRATIC PLACEBO

    AMPIO ALREADY HAS WRITTEN APPROVAL IN THE FORM OF AN "SPA" FROM FDA FOR AMPION IF PRIMARY ENDPOINTS ARE MET.

    MANUFACTURING FACILITY IS FDA APPROVED, OPERATIONAL, AND READY TO BEGIN MANUFACTURING AMPION THE DAY AFTER FDA GREEN LIGHT. FACTORY IS CAPABLE OF PRODUCING $8 BILLION PER YEAR AND REQUIRES ONLY 2 PEOPLE PER SHIFT TO OPERATE.

    WATCH VIDEOS ON AMPIO TO LEARN ABOUT THE HUGE RUNWAY FOR AMPION AND OPTINA.

    Predict shares will be trading over $6 when news hits and shares will EXPLODE to $12 to $15

    Also predict, shares will continue to rise MUCH higher for balance of year and beyond.

    We are all big boys and are ready for what's coming soon

    Sentiment: Strong Buy

  • All one has to do is read his hundreds of posts that are all the same. They ALL wind up throwing shade on Ampio

    Sentiment: Strong Buy

AMPE
0.99+0.0045(+0.46%)Jul 29 4:02 PMEDT